Olfactory and other sensory impairments in Alzheimer disease
Abstract
The vast increase in Alzheimer disease (AD) worldwide has grave implications for individuals, family support systems and the health-care systems that will attempt to cope with the disease. Early markers of the disease are essential for efficient selection of clinical trial participants for drug development and for timely treatment once an intervention becomes available. There is avid interest in noninvasive, inexpensive markers that have the potential to identify prodromal AD. This Review considers sensory impairments that have the potential to serve as early indicators of AD, with a focus on olfaction, hearing and vision. Current evidence regarding the potential markers of AD in each modality is examined, with a particular emphasis on olfaction and current findings that olfactory function is associated with prodromal AD. Research suggests that olfactory impairment is associated with other markers that signal the emergence of prodromal AD. Auditory impairment is associated with dementia in epidemiological studies and visual system deficits have been reported in AD; however, the emergence of these deficits in prodromal AD is unclear. Further research is necessary to address the relative sensitivity and specificity of olfactory, auditory and visual measures for the detection of prodromal AD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Eleven ROIs have nominally significant correlations with both behaviors, including key sensory regions (VCP, VCS, and MGD) linked to early symptoms of AD in humans.
“Eleven ROIs have nominally significant correlations with both behaviors (Supplementary Table 10), including key sensory regions (VCP, VCS, and MGD) linked to early symptoms of AD in humans71-74.”
From Magnetic resonance microscopy maps widespread effects of Alzheimer’s disease on brain structures and behavior in mice (2026) · cites this paper as [72]
The olfactory bulb, entorhinal cortex and hippocampal formation (all olfactory structures), as well as the brainstem, are the CNS regions that exhibit the earliest signs of pathology in both late-onset dementia and familial Alzheimer's disease.
“Interestingly, the olfactory bulb, entorhinal cortex and hippocampal formation (all olfactory structures), as well as the brainstem, are the CNS regions that exhibit the earliest signs of pathology in both late-onset dementia and familial Alzheimer’s disease21–23.”
From Chlamydia pneumoniae can infect the central nervous system via the olfactory and trigeminal nerves and contributes to Alzheimer’s disease risk (2022) · cites this paper as [22]
The citation lists haven’t been fetched yet
References 135 · Cited by 425
- Authors
- Murphy, C.
- Affiliations
- San Diego State University (US)
- Corresponding author
- Murphy, Claire
- ORCID
- Murphy, Claire
- Venue
- Nature Reviews Neurology
- Published
- 2018-12-10
- Volume
- 15
- Issue
- 1
- Pages
- 11-24
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- OpenAlex
- W2904614042
- Cited by
- 425
- References
- 135
- Citations by year
- 2026: 44 · 2025: 78 · 2024: 85 · 2023: 60 · 2022: 59 · 2021: 44 · 2020: 40 · 2019: 14
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (R01-AG004085-26)
- University of California, San Diego
- National Institute on Aging (R01AG004085)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Sensory Systems › Olfactory and Sensory Function Studies
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Keywords
- Alzheimer's disease, prodromal Alzheimer's disease, olfactory dysfunction, olfaction, hearing loss, visual impairment, sensory impairment, early diagnosis, biomarkers
- MeSH terms
- Alzheimer Disease, Olfaction Disorders, Auditory Diseases, Central, Humans, Vision Disorders, Biomarkers, Prodromal Symptoms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review